Medtech grants in South Korea

Closed

Funds industry-academia consortia that refine and scale up the manufacturing process for one class of cell or gene therapy, from quality control through to deployment.

Funds one project to map, replace, reduce and safely dispose of PFAS chemicals used in medicines, vaccines, devices and diagnostics.

Closed

Funds research proving the causal link between pollution exposure and neurological, neurodegenerative or neurodevelopmental disease, using biomarkers, imaging and long-term cohort data.

Closed

Funds research into the prevention, diagnosis and treatment of long-term health conditions that persist after a viral, bacterial, parasitic or fungal infection has cleared.

Closed

Funds pragmatic clinical trials testing tailored nutrition-based care to improve outcomes and quality of life for cancer patients aged 65 and older.

Closed

Funds research and digital interventions that curb the harm excessive or misguided technology use does to the mental health of children and young adults aged 15 to 24.

Closed

Funds research that updates the evidence and methods regulators use to assess medical devices, diagnostics and AI health tools, so safe innovations reach patients faster.

Closed

Funds transnational access to research infrastructure services in one of three areas — industrial biotechnology, radionuclide facilities, or climate prediction.

Closed

Funds transnational access to research infrastructure services for either epidemic-response research or paediatric clinical research, chosen as one area.

Funds one project to build frameworks, guidance and recommendations that protect IP, trade secrets and regulatory data when health data is reused under the EHDS.

Closed

Funds one coordination project that maps existing cardiovascular research and builds a strategic research and innovation agenda for cutting cardiovascular disease across the EU.

Closed

Funds research into how biological sex and gender shape cardiovascular disease risk, aiming for tailored prevention, diagnosis and treatment models for women and men.

Closed

Offers early-career deep-tech researchers a free venture-creation and pre-incubation programme with training, coaching and a European bootcamp.

Closed

Funds coordination of national Cancer Mission Hubs across EU and associated countries to run policy dialogues, citizen engagement and knowledge-sharing on cancer.

Closed

Funds SMEs and researchers building AI-backed digital tools that help people eat to prevent cardiovascular disease.

Closed

Funds a coordination action among national and regional cancer research funders to launch at least four joint transnational calls for translational cancer research.

Funds late-stage clinical trials of treatments and diagnostics for six climate-linked diarrhoeal disease pathogens in sub-Saharan Africa.

Closed

Funds clinical and pre-clinical research that pins down the causes of, and builds better diagnostics and treatments for, medical conditions that are common but poorly understood, such as ME/CFS, autism, gynaecological diseases and low back pain.

Funds one large data platform that identifies shared biological markers for reward, motivation and impulsivity symptoms across Alzheimer's, depression, obesity and related disorders.

Funds training, twinning and digital-platform networks that raise ethics, regulatory and pharmacovigilance capacity across sub-Saharan African health authorities.

Funds beyond-proof-of-concept innovations that make infectious-disease prevention, treatment or diagnostics cheaper, more accessible or better suited to sub-Saharan Africa.

Closed

Pays biomedical New Approach Methodology developers a fixed EUR 300,000 lump-sum grant to validate animal-free testing methods and prepare them for regulatory use.

Closed

Funds research into how climate change drives non-communicable disease, mental health harm or infectious disease, so health systems can better anticipate and respond.

Funds one project mining research cohorts and biobanks to find causal links between infections and non-communicable diseases, aimed at new vaccines, diagnostics and early treatments.